Fortress Biotech, Inc. financial data

Symbol
FBIO, FBIOP on Nasdaq
Industry
Pharmaceutical Preparations
Location
1111 Kane Concourse, Suite 301, Bay Harbor Islands, FL
State of incorporation
Delaware
Fiscal year end
December 31
Former names
CORONADO BIOSCIENCES INC (to 4/27/2015)
Latest financial report
10-Q - Q2 2024 - Aug 13, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 126 % -24.3%
Quick Ratio 12 % +7.81%
Debt-to-equity 822 % +44.8%
Return On Equity 539 %
Return On Assets -25.9 % +28.2%
Operating Margin -118 % +65.4%

Shares

Label TTM Value / Value Unit Change %
Common Stock, Shares, Outstanding 22.6M shares -82.8%
Entity Public Float 52.9M USD -20.3%
Common Stock, Value, Issued 23K USD -82.6%
Weighted Average Number of Shares Outstanding, Basic 18.3M shares +148%
Weighted Average Number of Shares Outstanding, Diluted 18.3M shares +148%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 82.6M USD +31.7%
Research and Development Expense 71.9M USD -47.4%
Costs and Expenses 180M USD -34.9%
Operating Income (Loss) -97.7M USD +54.4%
Nonoperating Income (Expense) -9.31M USD +8.38%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -10.6M USD +80.1%
Income Tax Expense (Benefit) 521K USD +16%
Net Income (Loss) Attributable to Parent -40.7M USD +57.5%
Earnings Per Share, Basic -3.11 USD/shares +86.3%
Earnings Per Share, Diluted -0.73 USD/shares +80%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 76.2M USD -2.33%
Accounts Receivable, after Allowance for Credit Loss, Current 10.5M USD -37.5%
Inventory, Net 9.69M USD -20.4%
Assets, Current 103M USD -18.9%
Property, Plant and Equipment, Net 3.55M USD -51%
Operating Lease, Right-of-Use Asset 14.6M USD -18.5%
Other Assets, Noncurrent 3.36M USD -6.05%
Assets 146M USD -19.4%
Accounts Payable, Current 38M USD -21.9%
Accrued Liabilities, Current 68.9M USD -30.5%
Liabilities, Current 75.5M USD -41.3%
Deferred Income Tax Liabilities, Net 233K USD
Operating Lease, Liability, Noncurrent 15.9M USD -18.3%
Other Liabilities, Noncurrent 1.8M USD +2.57%
Liabilities 160M USD -18.5%
Retained Earnings (Accumulated Deficit) -721M USD -5.98%
Stockholders' Equity Attributable to Parent 17.9M USD -3.42%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest -14.6M USD +8.44%
Liabilities and Equity 146M USD -19.4%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -25.4M USD +41.3%
Net Cash Provided by (Used in) Financing Activities 27.9M USD +25.6%
Net Cash Provided by (Used in) Investing Activities 0 USD
Common Stock, Shares Authorized 200M shares 0%
Common Stock, Shares, Issued 22.6M shares -82.8%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 2.47M USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 78.3M USD -12.3%
Interest Paid, Excluding Capitalized Interest, Operating Activities 1.66M USD -42.5%
Deferred Tax Assets, Valuation Allowance 366M USD +15.2%
Deferred Tax Assets, Gross 374M USD +14.7%
Operating Lease, Liability 18.4M USD -15.6%
Depreciation 1.36M USD -57.6%
Payments to Acquire Property, Plant, and Equipment 0 USD -100%
Lessee, Operating Lease, Liability, to be Paid 22.6M USD -18.2%
Property, Plant and Equipment, Gross 15.4M USD 0%
Operating Lease, Liability, Current 2.48M USD +6.53%
Lessee, Operating Lease, Liability, to be Paid, Year Two 3.27M USD -13.2%
Lessee, Operating Lease, Liability, to be Paid, Year One 3.54M USD -6.15%
Operating Lease, Weighted Average Discount Rate, Percent 0.06 pure -15.4%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 4.23M USD -27.8%
Lessee, Operating Lease, Liability, to be Paid, Year Three 2.92M USD -16.7%
Deferred Tax Assets, Operating Loss Carryforwards 211M USD +6.6%
Preferred Stock, Shares Issued 3.43M shares 0%
Preferred Stock, Shares Authorized 15M shares 0%
Unrecognized Tax Benefits 3.2M USD
Lessee, Operating Lease, Liability, to be Paid, Year Four 2.97M USD -7.02%
Operating Lease, Payments 920K USD +5.02%
Additional Paid in Capital 739M USD +5.75%
Preferred Stock, Shares Outstanding 3.43M shares 0%
Amortization of Intangible Assets 814K USD -23.9%
Deferred Tax Assets, Net of Valuation Allowance 7.52M USD -4.8%
Share-based Payment Arrangement, Expense 17.9M USD -15.8%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%